Clinical Trials on Calcitonin Gene-related Peptide Receptor
Total 221 results
-
Merck Sharp & Dohme LLCCompletedAngina Pectoris | Coronary Heart Disease | Calcitonin Gene-related Peptide Receptor
-
University Hospital Inselspital, BerneUniversity of Zurich; University Hospital MuensterCompletedPolymorphism, Genetic | Libido | Receptors, Androgen | Androgen EffectSwitzerland
-
Tianjin Medical University Second HospitalRecruitingSolid Tumor | FGF Receptor Gene Mutation | FGF Amplification | FGF Receptor Gene Family Rearrangement | FGF Receptor Gene TranslocationChina
-
St Vincent's Hospital, SydneyTerminatedSolid Tumor | Androgen Receptor Gene OverexpressionAustralia
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)SuspendedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | MLH1 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | BARD1 Gene Mutation | MSH2 Gene Mutation | MSH6... and other conditionsUnited States
-
Aristotle University Of ThessalonikiCompletedPoor Ovarian Response | Androgen Receptor Gene Overexpression | Normal Responders | Bologna Criteria
-
University of Eastern FinlandDSM Nutritional Products, Inc.CompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
University of Eastern FinlandCompletedVitamin D Receptor Target Gene Expression | Serum 25(OH)D ConcentrationFinland
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedEstrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative NeoplasmItaly
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Not yet recruitingGlucagon-Like Peptide-1 Receptor AgonistsChina
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Karen-Lise Garm SpindlerCompletedColorectal Cancer Metastatic | KRAS Gene Mutation | Circulating Tumor DNA | BRAF Gene Mutation | NRAS Gene Mutation | Epidermal Growth Factor Receptor InhibitorDenmark
-
University Hospital of FerraraRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide Therapy (PRRT)Italy
-
Medical University of GrazCompletedNFAT Regulated Gene Expression in Tacrolimus Treated PatientsAustria
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene MutationsUnited States, Israel, Canada, Germany, Greece, Italy, Portugal
-
University Medical Center NijmegenRecruitingOvarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene MutationNetherlands, United States, Belgium, Norway, Poland, Italy, Australia, Mexico, Brazil, Sweden, Uruguay
-
University of California, IrvineApplied Biology, Inc.WithdrawnCovid19 | Androgen Receptor Gene OverexpressionUnited States
-
Uppsala UniversityCompletedQuality of Life | Neuroendocrine Tumors | Peptide Receptor Radionuclide Therapy
-
University of VirginiaActive, not recruitingReal-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies (Lung001)Lung Cancer | ALK Gene Mutation | MET Gene Mutation | KRAS Mutation-Related Tumors | RET Gene Mutation | EGFR Gene Mutation | EGFR | ROS1 Gene Mutation | BRAFUnited States
-
Centro di Riferimento Oncologico - AvianoRecruitingBreast Neoplasms | Breast Diseases | Antineoplastic Agents | Aromatase Inhibitors | Neoplasms, Breast | Hormone Receptor Positive Breast Carcinoma | ESR1 Gene MutationItaly
-
National Institutes of Health Clinical Center (CC)RecruitingRyanodine Receptor 1-Related Myopathy | Ryanodine Receptor 1 Related DisordersUnited States
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
Eisai Inc.Active, not recruitingBreast Neoplasms | Receptors, Estrogen | Genes, Erbb-2United States, United Kingdom
-
Dr Cipto Mangunkusumo General HospitalCompletedColorectal Cancer | APC Gene Mutation | TP53 Gene Mutation | PIK3CA Gene Mutation | KRAS Mutation-Related Tumors | MLH1 Gene MutationIndonesia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHereditary Breast and Ovarian Cancer Syndrome | Premenopausal | Deleterious BARD1 Gene Mutation | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Deleterious BRIP1 Gene Mutation | Deleterious EPCAM Gene Mutation | Deleterious MLH1 Gene Mutation | Deleterious MSH2 Gene Mutation | Deleterious... and other conditionsUnited States
-
Genzyme, a Sanofi CompanyCompletedEye Diseases | Macular Degeneration | Retinal Degeneration | Gene Therapy | Age-Related Maculopathies | Age-Related Maculopathy | Retinal Neovascularization | Maculopathies, Age-Related | Maculopathy, Age-Related | Therapy, GeneUnited States
-
CHANGHEE LEEPurdue University; LG Electronics Inc.CompletedBCL2 Gene mRNA OverexpressionKorea, Republic of
-
Universiti Sains MalaysiaCompletedOpioid Dependence | Methadone Toxicity | HERG Gene MutationMalaysia
-
AstraZenecaCompletedAdvanced Solid Tumours With Androgen Receptor Pathway as a Potential FactorUnited Kingdom, United States
-
National Taiwan University HospitalRecruitingCancer | Drug-Related Side Effects and Adverse Reactions | Cancer, Treatment-Related | EGFR Gene MutationTaiwan
-
University of VirginiaRecruitingGenetic Predisposition | Gene Mutation-Related CancerUnited States
-
Institut CurieRecruitingGenetic Predisposition | Gene Mutation-Related CancerFrance, Guadeloupe, Martinique, Réunion
-
Xiangya Hospital of Central South UniversityCompletedDrug Reaction | Hemodynamic Rebound | Gene | AnestheticChina
-
University College, LondonNot yet recruitingMedullary Thyroid Carcinoma | Bronchial and Thymic Neuroendocrine Tumour | Paraganglioma/ Phaeochromocytoma | Those Requiring Repeat Peptide Receptor Radionuclide Therapy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBreast Carcinoma | Fallopian Tube Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Deleterious CDH1 Gene Mutation | Deleterious DICER1 Gene Mutation | Deleterious SMARCA4 Gene Mutation | Deleterious STK11 Gene MutationUnited States
-
PrECOG, LLC.ECOG-ACRIN Cancer Research GroupRecruitingNon Small Cell Lung Cancer | Stage IV Lung Cancer | Stage III Lung Cancer | Epidermal Growth Factor Receptor Gene MutationUnited States
-
AbbVieAbbVieEnrolling by invitationGene Therapy | AMD | nAMD | Wet AMD | Neovascular Age-Related Macular Degeneration (nAMD) | wAMDUnited States
-
NYU Langone HealthActive, not recruitingMLH1 Gene Mutation | RAD51C Gene Mutation | BRIP1 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | BRCA-Mutated Ovarian Carcinoma | MSH2 A636P | EPCAMUnited States
-
Ohio State University Comprehensive Cancer CenterImmunoGen, Inc.; Clovis Oncology, Inc.CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Folate Receptor Alpha Positive | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Uterine Serous Carcinoma | Recurrent Uterine Carcinosarcoma | Platinum...United States
-
Clinical Hospital Centre ZagrebRecruitingHypoglycemia | Pregnancy Outcomes | Glycemic Variability | C-peptide | Large-for-gestational-age NeonatesCroatia
-
Hemera BiosciencesWithdrawnGeographic Atrophy | Dry Age-related Macular Degeneration | Gene Therapy | Intravitreal Injection
-
University Health Network, TorontoAbbVie; CelgeneTerminatedAcute Myeloid Leukemia | Relapsed Cancer | Refractory Cancer | IDH2 Gene MutationCanada
-
National Taiwan University HospitalCompletedDiabetes and Healthy Control | FTO Gene Expression | Aerobic Exercise Intervention or Home Exercise | Pre-training and Post-trainingTaiwan
-
Uşak UniversityBahçeşehir University; Firat UniversityCompleted
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); London Health Sciences Centre; H. Lee Moffitt Cancer Center and Research Institute and other collaboratorsUnknownBreast Cancer | Ovarian Cancer | BRCA1 Gene Mutation | BRCA2 Gene MutationCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnPancreatic Ductal Adenocarcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Homologous Recombination Deficiency | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | ATM Gene Mutation | Deleterious BRCA1 Gene... and other conditions